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I. Significance/Context and Importance of the Study:  
Idiopathic normal pressure hydrocephalus (INPH) was first defined by Hakim and 
colleagues in 1965
1
, and its symptoms later classified by the clinical triad of gait 
dysfunction, urinary incontinence, and dementia. The exact pathophysiology of this 
disease is not well understood.
2
  Surgical options for the treatment of INPH are 
ventriculoperitoneal shunt (VPS) placement (most commonly with a programmable 
valve), and endoscopic third ventriculostomy (ETV).  VPS is by far the most common 
method used to treat INPH worldwide.  Debate exists as to the superiority between the 
two management options.  Historically, VPS placement with a programmable valve has 
led to improved outcomes with INPH.
3
  More recent use of ETV has been reported in the 
form of retrospective data, demonstrating neurological improvement in up to 69% of 
patients.
4
  However, a cited limitation of this study is the less stringent diagnostic criteria 
that fails to discriminate secondary NPH from INPH.  This is important because of the 
higher success rates of treatment in secondary NPH.
2
   This study by Pinto et al should be 
commended for its attempt to compare ETV to VPS with a nonprogrammable valve for 
patients with the diagnosis of INPH prospectively.  Given that the natural history of VPS 
carries a significant rate of shunt revision, there have been no prior attempts to provide 
level I evidence demonstrating equivalence or superiority of ETV to VPS placement. 
 
II. Originality of the work 
Literature pertaining to the surgical management of INPH exists largely in the form 
of retrospective cohort studies.  Prior retrospective studies have been previously reported 
showing that VPS placement is beneficial in 75% of 132 patients at 18 months follow-up 
with INPH.
2
  Likewise, there is no level I data pertaining to the use of ETV for the 
surgical treatment of INPH.  There is however, level I data (randomized, not controlled) 
comparing various settings of fixed pressure valves in the setting of INPH.  This present 
study is the first randomized clinical trial to compare therapeutic measures for INPH. 
 
III. Appropriateness of the study design or experimental approach 
The authors compare treatment of INPH with a VPS using a non-programmable 
valve (PS Medical, Medtronic, Minneapolis, MN) to an ETV in a randomized, parallel, 
open-labelled trial with enrollment in a 1:1 ratio.  The selection of a non-programmable 
valve is due to cost and availability.  Part of the inclusion criteria involves the ‘tap 
test’(TT) where a lumbar puncture is performed and 40 mL of CSF is drained.  They 
choose the tap test given its widely known validation and ease of use, despite its low 
sensitivity (<30%).  More sensitive methods such as the prolonged lumbar drain (up to 
100%) require higher technical expertise.  The authors improve upon prior methodology 
of retrospective studies which only utilize the classic symptoms in better defining INPH 
for trial inclusion by the addition of radiographic evidence, the tap test, and excluding 
patients with any history of primary dementia, intracranial pathology, or medical 
comorbidities that may introduce bias into the diagnostic process.  These stringent 
diagnostic criteria aim to limit the variability of results seen in the retrospective literature 
for surgical treatment of INPH.  
The trial however is likely severely underpowered to detect a significance between 
the study populations. The authors calculated the study population size using Altman’s 
nomogram and BERG score outcomes, for which they calculated 22 patients in each trial 
arm α=0.05 and power of 80%.  The BERG scores from ETV and VPS retrospective 
trials used for this calculation are not explicitly cited.  Recalculating the sample size 
using binary response rate (the primary outcome of this study being improvement of at 
least 2 points of the NPH score) yields significantly different results.  If the response rates 
of the cited retrospective studies are used, with 70% and 80% response rate after ETV 
and VPS respectively, a standard difference of 0.23 is calculated, resulting in study arms 
of 350 patients required to detect significant difference at α=0.05 and power of 80%.This 
failure to appropriately power the study may have been even greater had the authors 
explicitly defined the hypothesis.  Based on the stated rationale, it can be presumed that 
this trial is intended to be a non-inferiority trial, given the relatively similar response rates 
between ETV and VPS patients reported in the literature.  Using the above stated 
response rates, with δ=0.1, α=0.05, power of 80%, each study arm would require 878 
patients to detect a significant difference. 
Finally, failure of the trial to demonstrate equivalence in primary outcome can be 
anticipated from the primary cited study justifying ETV.  In the 2008 Italian study from 
Gangemi et al., a reponse rate of 69.1% was reported.  While not reported directly in that 
manuscript, post hoc analysis of the results demonstrates a mean improvement in NPH 
score of 1.34 points with standard deviation of 1.4.  As a result, only roughly a third of 
the patients in that study would have had a positive response as defined by the author’s 
primary outcome.   
IV. Adequacy of experimental techniques 
While many early studies have reviewed the efficacy of CSF diversion for INPH, 
their inclusion criteria are usually limited to ventriculomegaly, dementia, and ataxia.  
More modern study criteria include clinical as well as radiographic criteria (Evans Index 
> 0.30), as well as lumbar CSF drainage testing in attempts to limit many of the 
confounding factors that cloud the diagnosis of INPH.  
  
V. Soundness of conclusions and interpretation 
The authors conclude that neurologic improvement is superior in the VPS group, 
specifically with gait findings at 12 months.  It is difficult to reconcile that neurologic 
improvement is superior in the VPS group, and that it should be stressed that for this 
population of patients with INPH, conclusions can be made when they correlate with the 
specific diagnostic criteria in this study.   
As previously mentioned, INPH is a disease with multiple confounding factors.  
Across a number of studies, inclusion and exclusion criteria differ.  One of the largest 
series  reported by Vanneste et al
5
 of 131 patients found  only a 31% improvement in 
symptoms on follow-up, contrasted with the 75% found by McGirk and colleagues.
2
 
These dramatically different results should illustrate to the clinician interpreting this 
study that the variance in methods across studies matter.  For the conclusions of this 
study to translate over to a particular practice, ideally the diagnostic criteria for INPH 
should correlate between this trial and the neurosurgical practice.   
The authors also state that it would be difficult to recommend ETV based off of 
their study.  This statement is hard to reconcile given the design of the study.  The small 
patient population, the lack of a control population, and over half of the patients 
diagnosed with INPH excluded (n=48) by their criteria highlight the challenge of this 
study, along with the trial design limitations discussed above.  In addition to the large 
number of patients excluded prior to randomization, 5 of the 21 patients in the ETV arm 
were excluded due to anatomy that would add procedural risk.  Four additional patients 
treated with ETV did not improve and underwent VPS placement, whereupon they were 
removed from the final analysis.  The number of patients excluded from this study 
amounted to almost two-thirds of all patients diagnosed with INPH (57/90).  Therefore, 
the authors rightly conclude that future multicenter studies with larger patient populations 
are needed.   
 
VI. Relevance of discussion 
The authors begin the discussion with its limitations.  They emphasize that diagnostic 
criteria are important in defining INPH, a disease with symptoms that cannot be 
completely controlled for.  They draw on all of the prior literature and provide a more 
comprehensive diagnostic criteria for the study.  As a result, they exclude a large number 
of patients (45/90).  The authors use the ‘tap test’ as an inclusionary criteria for the study, 
despite its reportedly low sensitivity (26-61%).  They also mention the alternatives in 
diagnostic criteria.  Another key point raised is the type of VPS used, which is a fixed 
pressure valve in this study.  Programmable valves are commonly used in the US, often 
in conjunction with anti-siphon devices that prevent overdrainage.  Minor adjustments in 
these valves have been shown in retrospective studies to improve overall outcomes in 
NPH.
3
  The rationale for this practice in the US is illustrated by the 20% rate of subdural 
hematoma all of which required a surgical evacuation.   
 
VII. Clarity of writing, strength and organization of the paper 
The strength of this manuscript is derived from this novel attempt to compare two 
established treatments for INPH.  It is clearly written and easily understandable.  The 
discussion is well organized, beginning with the limitations of this study which comprises 
roughly half of the overall discussion.  The discussion then follows a logical progression 
of generalizability of the study and lastly interpretation.   
 
VIII. Economy of words 
This manuscript is concise and well-organized.  Given the exceedingly low 
number of clinical series on the surgical treatment of INPH, a table listing the prior 
contributions would be helpful to the reader, broken down into two sections, for ETV and 
VPS.     
 
IX. Relevance, accuracy and completeness of bibliography 
This manuscript is well-referenced, and included all of the clinical cohort studies on 
surgical treatment of INPH.  The first few references also include references to the original 
works by Hakim and Adams that discussed the early clinical symptoms of INPH.  
 
X. Number and quality of figures, tables and illustrations 
Figure 1 illustrates nicely the flow of enrollment in this study, illustrating the high 
number of patients excluded.  Table 1 summarizes the score at various time intervals for all 
of the clinical outcomes measured.  The scoring systems for the clinical outcomes are listed 
on a separate page in the methodology.  The scales are not organized alike in that higher 
scores for all groups do not interpret as improvement or decline.  It would be easier to read 
if the table had a legend that correlated increased numerical score correlated with clinical 
improvement or decline.  Figure 2 shows a typical patient that underwent an ETV, pre and 
post intervention.  This does not add much to the understanding of the study.  It may be 
more useful to show sagittal MR imaging of the patients that were excluded, to give the 
author an idea of what was deemed too unsafe to perform an ETV.  Excluding nearly 20% 
of potential candidates based off of anatomical variance alone is a high number and would 
be of interest to the reader.  Likewise, for a typical VPS patients, a preoperative and 
postoperative CTH was included to demonstrate what the authors considered an adequate 
cathether tip position.  This does not add much clarification to the methodology and 
probably can be removed from the study.   
 
XI. Future/next steps the paper logically leads to. 
Despite being clinically characterized in 1965, INPH to this date does not have a clear 
pathophysiology, nor has there been a demonstration in the literature as to a superior form of 
surgical management.  The authors in this study lay the groundwork for comparing surgical 
treatments for INPH.  Future resources should be devoted to multicenter, randomized, 
controlled trials (RCTs) with larger patient populations.  Given the considerable variation 
that is encountered between studies regarding diagnostic criteria for INPH, future studies 
should aim at standardizing this diagnostic process, in order to limit confounding variables 
due to disease overlap.  All steps must be taken to maximize the relevance of future RCTs, 
which would especially be the use of programmable valves with siphon guards. Follow-up 
times should exceed one year to gain a better sense of the need for reoperation rate, 
especially in the ETV group.   
 
 
References 
1. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic Occult Hydrocephalus 
with "Normal" Cerebrospinal-Fluid Pressure.A Treatable Syndrome. The New England journal of 
medicine. Jul 15 1965;273:117-126. 
2. McGirt MJ, Woodworth G, Coon AL, Thomas G, Williams MA, Rigamonti D. Diagnosis, treatment, 
and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus. Neurosurgery. 
Oct 2005;57(4):699-705; discussion 699-705. 
3. Zemack G, Romner B. Adjustable valves in normal-pressure hydrocephalus: a retrospective study 
of 218 patients. Neurosurgery. Dec 2002;51(6):1392-1400; discussion 1400-1392. 
4. Gangemi M, Maiuri F, Naddeo M, et al. Endoscopic third ventriculostomy in idiopathic normal 
pressure hydrocephalus: an Italian multicenter study. Neurosurgery. Jul 2008;63(1):62-67; 
discussion 67-69. 
5. Vanneste J, Augustijn P, Dirven C, Tan WF, Goedhart ZD. Shunting normal-pressure 
hydrocephalus: do the benefits outweigh the risks? A multicenter study and literature review. 
Neurology. Jan 1992;42(1):54-59. 
 
 
